Across TCGA pan-cancer cohorts, RPL37P10 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RPL37P10’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where RPL37P10 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPL37P10 is over-expressed in tumor.

STAD and KIRC are the cancer types where RPL37P10 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL37P10 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	All	All	+0.314	.004	3	view →
KIRC	All	All	+0.025	.048	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: RPL37P10 RNA expression & survival · all RPL37P10 data types